23andMe Scores FDA Clearance for Novel Cancer Immunotherapy Targeting NK Cells
What You Should Know: – 23andMe Holding Co. (Nasdaq: ME), a genetics and biopharmaceutical company, announced The U.S. Food and
Continue readingWhat You Should Know: – 23andMe Holding Co. (Nasdaq: ME), a genetics and biopharmaceutical company, announced The U.S. Food and
Continue readingA team at Columbia University School of Engineering and Applied Science has developed a technique to enhance chimeric antigen receptor
Continue reading